Frequent abnormalities of the P15 and P16 genes in mycosis fungoides and Sezary syndrome

Journal of Investigative Dermatology

Volumn 118, Issue 3, 2002, Pages 493-499

  Scarisbrick, Julia J ^a   Woolford, Alison J ^a   Calonje, Eduardo ^a   Photiou, Andrew ^a   Ferreira, Sylvia ^a   Orchard, Guy ^a   Russell Jones, Robin ^a   Whittaker, Sean J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Chromosome 9; Cutaneous T cell lymphoma; P15 and P16 genes

Indexed keywords

MICROSATELLITE DNA; PROTEIN P15; PROTEIN P16;

ALLELE; ARTICLE; CANCER STAGING; CHROMOSOME 10Q; CHROMOSOME 17P; CHROMOSOME 9P; CONTROLLED STUDY; GENE MUTATION; GENETIC CODE; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; METHYLATION; MYCOSIS FUNGOIDES; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SEZARY SYNDROME; SINGLE STRAND CONFORMATION POLYMORPHISM; T CELL LYMPHOMA;

EID: 0036121141     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0022-202x.2001.01682.x     Document Type: Article

References (59)

1. Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma
2. Frequent methylation silencing of p15 and p16 in B-cell and T-cell lymphomas
3. Cytogenetics of T-cell malignant lymphoma: Report of 17 cases and review of the chromosomal breakpoints
4. Allelic deletion at 9p21-22 in primary cutaneous CD30+ large cell lymphoma
5. CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas
6. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction
7. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
8. Review of alterations of the cyclin dependent kinases inhibitor INK4 family genes p15, p16, p18 and p19 in human leukaemia-lymphoma cells
9. Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukaemias and other haematologic malignancies
10. Cutaneous T-cell lymphoma: Mycosis fungoides, Sezary syndrome, and other variants
11. Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma
12. Hypermethylation of p14 is independent of p16 methylation and p53 mutational status
13. Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides
14. Deletions of the cyclin-dependant inhibitor genes p16 and p15 in non-Hodgkin's lymphoma
15. Methylation of the 5′-CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
16. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia
17. Candidate tumour suppressor gene MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not B-cell lineage acute lymphoblastic leukaemias
18. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
19. Distinct patterns of inactivation of p15 (INK4B) and p16 (INK4A) characterize the major types of hematological malignancies
20. Prognostic importance of p15INK4B and p16INK4 gene inactivation in childhood acute lymphocytic leukemia
21. Analysis of the P16 gene, CDKN2, in 17 Australian melanoma kindreds
22. CDKN2A (P16 INK4a) and CDK4 mutational analysis in 131 Australian melanoma probands: Effect of family history and multiple primary melanomas
23. Germline p16 mutations in familial melanoma
24. A cell cycle regulator potentially involved in genesis of many tumor types
25. Notable losses at specific regions of chromosome 10q and 13q in the Sezary syndrome detected by comparative genomic hybridization
26. Identification of three distinct tumour suppressor loci on the short arm of chromosome 9 in small cell lung cancer
27. Deletion of cyclin dependent kinase 4 inhibitor genes p15 and p16 in non-Hodgkin's lymphoma
28. Clinical staging for cutaneous T-cell lymphoma
29. p53 protein expression in cutaneous T-cell lymphomas
30. Analysis of p53 and mdm-2 expression in 18 patients with Sezary syndrome
31. Hypermethylation of a 5′-CpG island of p16 is a frequent event in non-Hodgkin's lymphoma
32. Hypermethylation of p15/ink4b/MTS2 gene is differentially implicated amoung non-Hodgkin's lymphoma
33. Spectrum of p53 gene mutations suggests a possible role for ultraviolet radiation in the pathogenesis of advanced cutaneous lymphomas
34. 5′-CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
35. p16 gene alterations are frequent in lesions of mycosis fungoides
36. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemias
37. Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21
38. Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukaemias and lymphomas
39. Reduced expression of CDKN2a/P16INK4a in mycosis fungoides
40. UTRdb and UTR site: Specialized databases of sequences and functional elements of 5′- and 3′-untranslated regions in eukaryotic mRNAs
41. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas
42. p16 (INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas
43. The Ink4a tumour suppressor gene product, p19Arf, interacts with and neutralises MDM2′s inhibition of p53
44. Alternative reading frames of the INK4a tumour suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest
45. p16 gene homozygous deletions in acute lymphoblastic leukaemia
46. p15 and p16 gene inactivation in acute lymphocytic leukaemia
47. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma
48. TCR gene analysis in the diagnosis of Sezary syndrome
49. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer
50. Loss of heterozygosity on 10q and microsatellite instability in advanced stages of primary cutaneous T-cell lymphoma and possible association with homozygous deletion of PTEN
51. Allelotyping in mycosis fungoides and Sezary syndrome: Common regions of allelic loss identified on 9p, 10q and 17p
52. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
53. Analysis of a family of cyclin-dependent kinase inhibitors. p15/MTS2/INK4B, 16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood
54. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression
55. Analysis of beta, gamma and delta TCR genes in mycosis fungoides and Sezary syndrome
56. Diagnostic criteria in Sezary's syndrome: A multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma
57. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
58. Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients
59. ARF promotes MDM2 degradation and stabilises p53. ARF-INK4a locus deletion impairs both the Rb and p53 tumour suppressor pathways